Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP.

Gong, Yuxi; Yan, Haitao; Yang, Yefan; Zhai, Boya; Huang, Zhendong; Zhang, Zhihong

Gong, Yuxi; Yan, Haitao; Yang, Yefan; Zhai, Boya; Huang, Zhendong; Zhang, Zhihong.

Afiliação

Gong Y; Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Yan H; Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Yang Y; Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Zhai B; Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Huang Z; Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Zhang Z; Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

Pharmgenomics Pers Med ; 16: 291-301, 2023.

Article em En | MEDLINE | ID: mdl-37035544

Palavras-chave

DLBCL; diffuse large B cell lymphoma; nomogram; recurrence; risk factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmgenomics Pers Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google